Gillette, NJ, United States of America

Suzanne C Aldous



Average Co-Inventor Count = 10.3

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Suzanne C Aldous: Innovator in Pharmaceutical Compounds**

Introduction: **Suzanne C Aldous** is a notable inventor based in **Gillette, NJ (US)**, recognized for her contributions to the field of pharmaceuticals. With **two patents** to her name, she has developed innovative compounds aimed at addressing allergic and inflammatory disorders.

Latest Patents: **Suzanne's latest inventions include:**

1. **Pyrimidine Hydrazide Compounds as PGDS Inhibitors** - This invention is directed to a compound of formula (I), where R, R, R, and L are defined within the patent. The pharmaceutical composition comprises the compound, which is used to treat allergic and/or inflammatory disorders, particularly conditions such as allergic rhinitis, asthma, and chronic obstructive pulmonary disease (COPD).

2. **Pyrimidine Amide Compounds as PGDS Inhibitors** - Similar to the previous invention, this patent also focuses on a compound of formula (I) with defined R values. It includes a pharmaceutical composition comprising the compound with applications for treating allergic and/or inflammatory disorders, impacting conditions like allergic rhinitis, asthma, and COPD.

Career Highlights: **Throughout her career**, Suzanne has made significant strides while working with major pharmaceutical companies. She has lent her expertise to renowned firms such as **Sanofi** and **Aventis Pharmaceuticals Inc.**, contributing to the development of various pharmaceutical solutions.

Collaborations: **Suzanne has collaborated with esteemed colleagues**, including **John Ziqi Jiang** and **Lan Mu**. These collaborations have enriched her research and the innovative processes that have led to her patent achievements.

Conclusion: **Suzanne C Aldous** stands out as a remarkable inventor in the pharmaceutical landscape. Her work on PGDS inhibitors not only reflects her dedication to addressing important health issues but also showcases her commitment to innovation in medicine. Through her patents, she continues to pave the way for advancements in treatments for allergic and inflammatory disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…